Rain Therapeutics Inc. (RAIN) NASDAQ
$1.21 (0.02) (-1.63%)
Market Cap: $44.01M
As of 01/25/24 04:00 PM EST. Market closed.
Rain Therapeutics Inc. (RAIN)
NASDAQ
$1.21
(0.02) (-1.63%)
Market Cap: $44.01M
As of 01/25/24 04:00 PM EST. Market closed.
Add to Portfolio
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Avanish Vellanki M.B.A.
Full Time Employees
63
CEO Compensation (Base)
$590,310
CEO Compensation (Total)
$2.19M
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Avanish Vellanki M.B.A.
Full Time Employees
63
CEO Compensation (Base)
$590,310
CEO Compensation (Total)
$2.19M
Address
8000 Jarvis Avenue, CA, Newark, 94560.
PRICE CHART FOR RAIN THERAPEUTICS INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.24
Previous Close
$1.23
Days Range
$1.21 - $1.27
52 week range
$0.82 - $11.32
Volume
3,699,464
Avg. Volume (30 days)
238,293
Market Cap
$44.01M
Dividend Yield
-
P/E
(0.58)
Shares Outstanding
36,375,702
Open
$1.24
Previous Close
$1.23
Days Range
$1.21 - $1.27
52 week range
$0.82 - $11.32
Volume
3,699,464
Avg. Volume (30 days)
238,293
Market Cap
$44.01M
Dividend Yield
-
P/E
(0.58)
Shares Outstanding
36,375,702
FINANCIAL STATEMENTS FOR RAIN THERAPEUTICS INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR RAIN THERAPEUTICS INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| TANG KEVIN C | 10% Owner | Dec 18, 2023 | Sale | $1.21 | 40,132 | 48,560 | 3,850,513 | Dec 18, 2023, 06:29 PM |
| TANG KEVIN C | 10% Owner | Dec 15, 2023 | Sale | $1.20 | 109,435 | 131,322 | 3,890,645 | Dec 18, 2023, 06:29 PM |
| TANG KEVIN C | 10% Owner | Dec 14, 2023 | Sale | $1.21 | 24,406 | 29,531 | 4,000,080 | Dec 18, 2023, 06:29 PM |
| TANG KEVIN C | 10% Owner | Oct 13, 2023 | Buy | $0.99 | 131,631 | 130,315 | 4,024,486 | Oct 13, 2023, 04:57 PM |
| TANG KEVIN C | 10% Owner | Oct 12, 2023 | Buy | $0.98 | 77,702 | 76,148 | 3,892,855 | Oct 13, 2023, 04:57 PM |
| TANG KEVIN C | 10% Owner | Oct 11, 2023 | Buy | $0.97 | 74,812 | 72,568 | 3,815,153 | Oct 13, 2023, 04:57 PM |
| TANG KEVIN C | 10% Owner | Jun 01, 2023 | Buy | $1.11 | 333,325 | 370,534 | 3,740,341 | Jun 01, 2023, 06:46 PM |
| TANG KEVIN C | 10% Owner | May 31, 2023 | Buy | $1.08 | 166,180 | 179,574 | 3,407,016 | Jun 01, 2023, 06:46 PM |
| TANG KEVIN C | 10% Owner | May 30, 2023 | Buy | $1.03 | 588,768 | 608,655 | 3,240,836 | Jun 01, 2023, 06:46 PM |
| Boxer Capital, LLC | See remarks. | May 22, 2023 | Sale | $1.25 | 995,000 | 1,243,750 | 1,152,212 | May 24, 2023, 08:05 PM |
| BERGER FRANKLIN M | Director | Nov 22, 2022 | Buy | $8.27 | 77,000 | 636,790 | 1,005,207 | Nov 23, 2022, 05:45 PM |
| BERGER FRANKLIN M | Director | Nov 21, 2022 | Buy | $7.80 | 45,000 | 351,000 | 928,207 | Nov 23, 2022, 05:45 PM |
| BERGER FRANKLIN M | Director | Nov 08, 2022 | Buy | $5.83 | 42,881 | 249,996 | 883,207 | Nov 14, 2022, 04:17 PM |
| BVF PARTNERS L P/IL | Director | Nov 08, 2022 | Buy | $5.83 | 1,710,358 | 9,971,387 | 2,870,985 | Nov 10, 2022, 06:31 PM |
| Davis Aaron I. | Director | Nov 04, 2022 | Buy | $5.83 | 972,212 | 5,667,996 | 2,147,212 | Nov 08, 2022, 04:30 PM |
| Doebele Robert | See Remarks | Jul 06, 2022 | Option Exercise | $3.95 | 3,890 | 15,366 | 476,827 | Jul 07, 2022, 06:02 PM |
| Vellanki Avanish | Chairman and CEO | Jun 01, 2022 | Buy | $2.29 | 25,000 | 57,250 | 2,471,627 | Jun 02, 2022, 04:05 PM |
| Doebele Robert | See Remarks | Apr 13, 2022 | Option Exercise | $3.95 | 3,000 | 11,850 | 472,937 | Apr 15, 2022, 04:30 PM |
| Doebele Robert | See Remarks | Mar 31, 2022 | Option Exercise | $3.95 | 2,000 | 7,900 | 469,937 | Apr 04, 2022, 04:15 PM |
| Vellanki Avanish | President and CEO | Mar 11, 2022 | Option Exercise | $4.00 | 14,468 | 57,872 | 2,837,009 | Mar 15, 2022, 03:23 PM |
| BVF PARTNERS L P/IL | Director | Jan 06, 2022 | Buy | $12.00 | 61,343 | 736,018 | 1,141,759 | Jan 10, 2022, 06:03 PM |
| BVF PARTNERS L P/IL | Director | Jan 07, 2022 | Buy | $12.00 | 496,385 | 5,956,620 | 1,734,960 | Jan 10, 2022, 06:03 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Oct 07, 2021 | Sale | $14.81 | 13,368 | 197,918 | 2,523,937 | Oct 13, 2021, 05:47 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Oct 12, 2021 | Sale | $13.40 | 7,306 | 97,900 | 2,487,019 | Oct 13, 2021, 05:47 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Oct 11, 2021 | Sale | $12.51 | 21,826 | 273,040 | 2,503,676 | Oct 13, 2021, 05:47 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Oct 08, 2021 | Sale | $13.15 | 7,500 | 98,621 | 2,518,613 | Oct 13, 2021, 05:47 PM |
| BVF PARTNERS L P/IL | Director | Sep 21, 2021 | Buy | $13.94 | 11,033 | 153,829 | 1,479,460 | Sep 23, 2021, 08:05 PM |
| BERGER FRANKLIN M | Director | Sep 21, 2021 | Buy | $14.30 | 3,786 | 54,140 | 840,326 | Sep 23, 2021, 05:21 PM |
| BVF PARTNERS L P/IL | Director | Sep 13, 2021 | Buy | $16.49 | 392,269 | 6,468,516 | 1,473,119 | Sep 15, 2021, 05:23 PM |
| BVF PARTNERS L P/IL | Director | Jul 06, 2021 | Buy | $15.25 | 269,723 | 4,113,276 | 1,259,873 | Jul 06, 2021, 07:34 PM |
| BVF PARTNERS L P/IL | Director | Jul 01, 2021 | Buy | $15.65 | 317,279 | 4,965,416 | 1,113,757 | Jul 06, 2021, 07:34 PM |
| BVF PARTNERS L P/IL | Director | May 24, 2021 | Buy | $15.90 | 1,361 | 21,633 | 941,300 | May 25, 2021, 08:31 PM |
| BVF PARTNERS L P/IL | Director | May 21, 2021 | Buy | $15.94 | 121,986 | 1,944,701 | 940,581 | May 25, 2021, 08:31 PM |
| BVF PARTNERS L P/IL | Director | May 19, 2021 | Buy | $15.88 | 17,268 | 274,290 | 874,339 | May 20, 2021, 07:18 PM |
| BVF PARTNERS L P/IL | Director | May 18, 2021 | Buy | $16.65 | 191,197 | 3,183,430 | 865,148 | May 20, 2021, 07:18 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Apr 27, 2021 | Buy | $17.00 | 450,000 | 7,650,000 | 2,776,657 | Apr 29, 2021, 04:02 PM |
| BVF PARTNERS L P/IL | Director | Apr 26, 2021 | Option Exercise | $14.90 | 27,413 | 408,478 | 729,732 | Apr 27, 2021, 08:41 PM |
| BVF PARTNERS L P/IL | Director | Apr 23, 2021 | Option Exercise | $16.90 | 1,105,896 | 18,694,901 | 714,942 | Apr 27, 2021, 08:41 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 27, 2021 | Buy | $17.00 | 550,000 | 9,350,000 | 2,537,019 | Apr 27, 2021, 07:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR RAIN THERAPEUTICS INC.
STOCK BUYBACKS FOR RAIN THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
0.03%
1Q
03/31/2023
0.10%
2Q
12/31/2022
12.50%
3Q
09/30/2022
36.93%
4Q
06/30/2022
37.11%
5Q
03/31/2022
37.21%
6Q
12/31/2021
87.45%
7Q
09/30/2021
37.44%
8Q
06/30/2021
74.67%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR RAIN THERAPEUTICS INC.
LOADING...